The Temporary Cardiac Pacing Wires Leads Market To Get Back To The Holistic
Mode With A CAGR Of 6.6%
The Temporary Cardiac Pacing Wires Leads Market report by Persistence Market Research is
focusing on the fact that healthcare providers are into collection of socioeconomic information
of the patients, so that tracking at any point of time is possible. This on-the-go monitoring is
amongst the ongoing trends in the healthcare industry.
The prevalence of arrhythmia and cardiovascular diseases is rising and expected to continue
growing throughout the forecast period. According to the latest research by the company, the
global temporary cardiac pacing wires & leads market is anticipated to account for over US$
411.5 Mn in terms of value by 2026 end. The report on the temporary cardiac pacing wires &
leads market indicates that the market is projected to have significant growth potential through
The minimally-invasive procedure for transvenous pacing, by techniques type, is projected to
account for the largest revenue share throughout the forecast period. The increasing adoption
of the minimally-invasive technique for temporary pacing during emergencies such as acute
myocardial infarction and heart block is expected to drive the market for temporary cardiac
pacing wires & leads in the near future.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25129
BioTrace Medical Inc.
Becton, Dickinson and Company (C.R. Bard)
B. Braun Melsungen AG
Abbott Laboratories (St. Jude Medical)
Edwards Lifesciences Corporation
A&E Medical Corporation
The favorable reimbursement scenario for the treatment of cardiovascular diseases, as the
burden for cardiovascular diseases continues to increase in developing and under-developed
economies, contributes to the growth of the temporary cardiac pacing wires & leads market.
Significant growth in the number of cardiac surgeries